New pill for eczema shows promise in early safety trial

NCT ID NCT06945458

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested an oral medication called KT-621 in 22 adults with moderate to severe atopic dermatitis (eczema). The main goal was to check safety and how the body processes the drug. Researchers monitored side effects and drug levels in the blood, but did not measure how well it treats the condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kymera Investigative Site

    Birmingham, Alabama, 35244, United States

  • Kymera Investigative Site

    Fountain Valley, California, 92708, United States

  • Kymera Investigative Site

    Santa Monica, California, 90404, United States

  • Kymera Investigative Site

    Boynton Beach, Florida, 33436, United States

  • Kymera Investigative Site

    Hollywood, Florida, 33024, United States

  • Kymera Investigative Site

    Tampa, Florida, 33613, United States

  • Kymera Investigative Site

    Fargo, North Dakota, 58078, United States

  • Kymera Investigative Site

    Dublin, Ohio, 43016, United States

  • Kymera Investigative Site

    Springfield, Ohio, 45505, United States

  • Kymera Investigative Site

    Tulsa, Oklahoma, 74136, United States

  • Kymera Investigative Site

    Charleston, South Carolina, 29420, United States

  • Kymera Investigative Site

    San Antonio, Texas, 78213, United States